Your browser doesn't support javascript.
loading
Genomic epidemiology reveals the impact of national and international restrictions measures on the SARS-CoV-2 epidemic in Brazil.
Giovanetti, Marta; Slavov, Svetoslav Nanev; Fonseca, Vagner; Wilkinson, Eduan; Tegally, Houriiyah; Patané, José Salvatore Leister; Viala, Vincent Louis; San, James Emmanuel; Rodrigues, Evandra Strazza; Santos, Elaine Vieira; Aburjaile, Flavia; Xavier, Joilson; Fritsch, Hegger; Adelino, Talita Emile Ribeiro; Pereira, Felicidade; Leal, Arabela; de Melo Iani, Felipe Campos; de Carvalho Pereira, Glauco; Vazquez, Cynthia; Mercedes Estigarribia Sanabria, Gladys; de Oliveira, Elaine Cristina; Demarchi, Luiz; Croda, Julio; Dos Santos Bezerra, Rafael; de Lima, Loyze Paola Oliveira; Martins, Antonio Jorge; Dos Santos Barros, Claudia Renata; Marqueze, Elaine Cristina; de Souza Todao Bernardino, Jardelina; Moretti, Debora Botequio; Brassaloti, Ricardo Augusto; de Lello Rocha Campos Cassano, Raquel; Mariani, Pilar Drummond Sampaio Corrêa; Kitajima, João Paulo; Santos, Bibiana; Proto-Siqueira, Rodrigo; Cantarelli, Vlademir Vicente; Tosta, Stephane; Nardy, Vanessa Brandão; de Oliveira da Silva, Luciana Reboredo; Kelly Astete Gómez, Marcela; Lima, Jaqueline Gomes; Ribeiro, Adriana Aparecida; Guimarães, Natália Rocha; Watanabe, Luiz Takao; Da Silva, Luana Barbosa; da Silva Ferreira, Raquel; da Penha, Mara Patricia F; Ortega, María José; de la Fuente, Andrea Gómez.
Afiliação
  • Giovanetti M; Laboratório de Flavivírus, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Slavov SN; Laboratório de Genética Celular e Molecular, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Fonseca V; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Wilkinson E; Butantan Institute, São Paulo, Brazil.
  • Tegally H; Laboratório de Flavivírus, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Patané JSL; Coordenação Geral de Laboratórios de Saúde Pública/Secretaria de Vigilância em Saúde, Ministério da Saúde (CGLAB/SVS-MS) Brasília, Distrito Federal, Brazil.
  • Viala VL; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • San JE; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University; Stellenbosch, South Africa.
  • Rodrigues ES; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Santos EV; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University; Stellenbosch, South Africa.
  • Aburjaile F; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Xavier J; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University; Stellenbosch, South Africa.
  • Fritsch H; Butantan Institute, São Paulo, Brazil.
  • Adelino TER; Butantan Institute, São Paulo, Brazil.
  • Pereira F; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Leal A; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University; Stellenbosch, South Africa.
  • de Melo Iani FC; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • de Carvalho Pereira G; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Vazquez C; Laboratório de Genética Celular e Molecular, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Mercedes Estigarribia Sanabria G; Laboratório Central de Saúde Pública do Estado de Minas Gerais, Fundac ão Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil.
  • de Oliveira EC; Laboratório de Flavivírus, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Demarchi L; Laboratório Central de Saúde Pública do Estado de Minas Gerais, Fundac ão Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil.
  • Croda J; Laboratório de Flavivírus, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Dos Santos Bezerra R; Laboratório Central de Saúde Pública do Estado de Minas Gerais, Fundac ão Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil.
  • de Lima LPO; Laboratório de Flavivírus, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Martins AJ; Laboratório Central de Saúde Pública do Estado de Minas Gerais, Fundac ão Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil.
  • Dos Santos Barros CR; Laboratorio Central de Saude Publica da Bahia-LACEN-BA, Salvador, Bahia, Brazil.
  • Marqueze EC; Laboratorio Central de Saude Publica da Bahia-LACEN-BA, Salvador, Bahia, Brazil.
  • de Souza Todao Bernardino J; Laboratório Central de Saúde Pública do Estado de Minas Gerais, Fundac ão Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil.
  • Moretti DB; Laboratório Central de Saúde Pública do Estado de Minas Gerais, Fundac ão Ezequiel Dias, Belo Horizonte, Minas Gerais, Brazil.
  • Brassaloti RA; Laboratorio Central de Salud Pública, Asunción, Paraguay.
  • de Lello Rocha Campos Cassano R; Universidad Nacional del Caaguazú, Instituto Regional de Investigación en Salud.
  • Mariani PDSC; Laboratorio de Biología Molecular, Hospital Regional de Coronel Oviedo.
  • Kitajima JP; Ministerio de Salud Pública y Bienestar Social.
  • Santos B; Laboratório Central de Saúde Pública do Estado de Mato Grosso, Cuiabá, Brazil.
  • Proto-Siqueira R; Laboratório Central de Saúde Pública do Estado de Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
  • Cantarelli VV; Universidade Federal de Mato Grosso do Sul.
  • Tosta S; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Nardy VB; Butantan Institute, São Paulo, Brazil.
  • de Oliveira da Silva LR; Butantan Institute, São Paulo, Brazil.
  • Kelly Astete Gómez M; Butantan Institute, São Paulo, Brazil.
  • Lima JG; Butantan Institute, São Paulo, Brazil.
  • Ribeiro AA; Butantan Institute, São Paulo, Brazil.
  • Guimarães NR; Butantan Institute, São Paulo, Brazil.
  • Watanabe LT; University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil.
  • Da Silva LB; University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil.
  • da Silva Ferreira R; NGS Soluções Genômicas, Piracicaba, SP, Brazil.
  • da Penha MPF; Mendelics Análise Genômica.
  • Ortega MJ; Mendelics Análise Genômica.
  • de la Fuente AG; Instituto de Biologia Molecular, Laboratório Antonello, Rio Grande do Sul, Brazil.
medRxiv ; 2022 Mar 28.
Article em En | MEDLINE | ID: mdl-35378755
ABSTRACT
Brazil has experienced some of the highest numbers of COVID-19 cases and deaths globally and from May 2021 made Latin America a pandemic epicenter. Although SARS-CoV-2 established sustained transmission in Brazil early in the pandemic, important gaps remain in our understanding of virus transmission dynamics at the national scale. Here, we describe the genomic epidemiology of SARS-CoV-2 using near-full genomes sampled from 27 Brazilian states and a bordering country - Paraguay. We show that the early stage of the pandemic in Brazil was characterised by the co-circulation of multiple viral lineages, linked to multiple importations predominantly from Europe, and subsequently characterized by large local transmission clusters. As the epidemic progressed under an absence of effective restriction measures, there was a local emergence and onward international spread of Variants of Concern (VOC) and Variants Under Monitoring (VUM), including Gamma (P.1) and Zeta (P.2). In addition, we provide a preliminary genomic overview of the epidemic in Paraguay, showing evidence of importation from Brazil. These data reinforce the usefulness and need for the implementation of widespread genomic surveillance in South America as a toolkit for pandemic monitoring that provides a means to follow the real-time spread of emerging SARS-CoV-2 variants with possible implications for public health and immunization strategies.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil